Genentech

Developer of pharmaceutical products intended to serve people with serious and life-threatening diseases. The company offers pharmaceutical products that have applications in ophthalmology, metabolism and virology fields, including antibodies for cancer and medicine for primary progressive multiple sclerosis. thereby enabling patients to avail the treatment of life-threatening diseases to live healthier lives.

Lonza Group AG is a Swiss multinational manufacturing company based in Basel, specializing in contract development and manufacturing services for the pharmaceutical, biotechnology, and nutrition sectors. Founded in 1897, Lonza has evolved from its origins in hydroelectric power to become a leader in biopharmaceutical manufacturing, operating over thirty development and manufacturing sites worldwide. As a pure-play contract development and manufacturing organization (CDMO), Lonza offers a wide range of services, including biologics manufacturing, small molecules production, bioconjugates, and cell and gene therapies. The company also provides drug product services and detection systems for the bioscience sector. Lonza has established significant partnerships with major pharmaceutical companies, including a notable collaboration with Moderna for the production of its COVID-19 vaccine. With a strong market position, Lonza plays a crucial role in the growth of outsourced drug manufacturing and the development of innovative therapies.

Developer of a science illustration software designed to empower the world to learn and communicate science through visuals. The company's platform permits scientists to create their compositions without any drawing, export their custom images in their preferred format and showcase their research, enabling scientists to quickly and easily communicate their research.